文献速递泌尿生殖介入外周血管DSACT

乙烯-乙烯醇共聚物栓塞治疗急性肾出血:24例初步经验

Ethylene Vinyl Alcohol Copolymer Embolization for Acute Renal Hemorrhage: Initial Experience in 24 Cases.
PubMed 文献 · AJR Am J Roentgenol · 2019-11-12

本研究评估乙烯-乙烯醇共聚物(EVOH)栓塞治疗急性肾出血的疗效与安全性。2006年10月至2018年6月连续24例患者接受EVOH栓塞,技术和临床成功率均为100%,平均随访35个月无再出血或需手术,无严重并发症,平均梗死肾面积10%。

要点

  • EVOH共聚物可用于急性肾出血的一线栓塞或弹簧圈栓塞失败后的补救栓塞。
  • 24例技术成功率和临床成功率均为100%,平均随访35个月无再出血、无需手术或再次栓塞。
  • 平均梗死肾面积10%(范围5%-30%),16例可评估患者栓塞后1周肾功能未改变。

核心结论

  • EVOH共聚物用于急性肾出血栓塞安全有效,可作为一线栓塞剂或在弹簧圈栓塞失败后使用。

研究设计与样本

  • 回顾性分析2006年10月至2018年6月在Hôpital Bichat-Claude-Bernard连续治疗的24例急性肾出血患者,均行EVOH共聚物栓塞。
  • 所有患者治疗前均行CT血管成像,技术成功定义为最终肾动脉造影上出血动脉完全闭塞,临床成功定义为栓塞后无再出血。

关键影像表现/征象

  • 所有病例均观察到活动性出血。
  • 急性肾出血原因:医源性12例、血管畸形4例、肾肿瘤4例、原因不明4例。

诊断标准与关键数值

  • 技术成功率和临床成功率均为100%。
  • 平均随访35个月(范围6-86个月),无患者需手术或再次栓塞。

临床应用与阅片要点

  • 16例患者仅使用EVOH共聚物作为栓塞剂,8例在弹簧圈栓塞后持续出血时改用EVOH共聚物。
  • 无严重并发症归因于EVOH共聚物,平均梗死肾面积10%(范围5%-30%)。
  • 16例(67%)患者栓塞后1周肾功能未改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to assess the efficacy and safety of ethylene vinyl alcohol (EVOH) copolymer (Onyx, Medtronic) for embolization for acute renal hemorrhage. MATERIALS AND METHODS. Between October 2006 and June 2018, 24 consecutive patients were treated by embolization with EVOH copolymer for acute renal hemorrhage at Hôpital Bichat-Claude-Bernard. CT angiography was performed in all patients before treatment. Technical success was defined as the complete occlusion of the bleeding artery on final renal angiogram. Clinical success was defined as the absence of rebleeding after embolization. Complications mid procedure, infarcted renal area on final angiogram, and renal function 1 week after embolization were retrospectively analyzed. RESULTS. Active bleeding was observed in all cases. The causes of acute renal hemorrhage were iatrogenic in 12 patients, vascular malformation in four patients, renal tumor in four patients, and unknown in four patients. EVOH copolymer was the sole embolic agent used in 16 patients. In eight patients, EVOH copolymer was used after persistent bleeding after embolization with coils. Technical and clinical success rates were 100%. No patient required surgery or new embolization during a mean follow-up period of 35 months (range, 6-86 months). No serious complications were attributable to EVOH copolymer. The mean infarcted renal area was 10% (range, 5-30%). Renal function, available for 16 (67%) patients, was not altered 1 week after embolization. CONCLUSION. EVOH copolymer is safe and effective for embolization of acute renal hemorrhage, either as a first-line embolic agent or after failure of coil embolization.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Mahdjoub E, Serhal A, Males L, et al. Ethylene Vinyl Alcohol Copolymer Embolization for Acute Renal Hemorrhage: Initial Experience in 24 Cases. AJR Am J Roentgenol. 2019. PMID: 31714850. doi:10.2214/AJR.19.21508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。